Your browser doesn't support javascript.
Hybrid immunity in immunocompromised patients with CLL after SARS-CoV-2 infection followed by booster mRNA vaccination.
Blixt, Lisa; Gao, Yu; Wullimann, David; Murén Ingelman-Sundberg, Hanna; Muschiol, Sandra; Healy, Katie; Bogdanovic, Gordana; Pin, Elisa; Nilsson, Peter; Kjellander, Christian; Grifoni, Alba; Sette, Alessandro; Sällberg Chen, Margaret; Ljunggren, Hans-Gustaf; Buggert, Marcus; Hansson, Lotta; Österborg, Anders.
  • Blixt L; Department of Hematology, Karolinska University Hospital Solna, Stockholm, Sweden.
  • Gao Y; Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden.
  • Wullimann D; Department of Medicine Huddinge, Center for Infectious Medicine, Karolinska Institutet, Stockholm, Sweden.
  • Murén Ingelman-Sundberg H; Department of Medicine Huddinge, Center for Infectious Medicine, Karolinska Institutet, Stockholm, Sweden.
  • Muschiol S; Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden.
  • Healy K; Department of Oncology, Karolinska University Hospital Solna, Stockholm, Sweden.
  • Bogdanovic G; Department of Clinical Microbiology, Karolinska University Hospital Solna, Stockholm, Sweden.
  • Pin E; Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden.
  • Nilsson P; Department of Dental Medicine, Karolinska Institutet, Huddinge, Sweden.
  • Kjellander C; Department of Clinical Microbiology, Karolinska University Hospital Solna, Stockholm, Sweden.
  • Grifoni A; Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden.
  • Sette A; Department of Protein Science, SciLifeLab, KTH Royal Institute of Technology, Stockholm, Sweden.
  • Sällberg Chen M; Department of Protein Science, SciLifeLab, KTH Royal Institute of Technology, Stockholm, Sweden.
  • Ljunggren HG; Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden.
  • Buggert M; Department of Internal Medicine, Capio St Göran Hospital, Stockholm, Sweden.
  • Hansson L; Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, La Jolla, CA.
  • Österborg A; Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, La Jolla, CA.
Blood ; 140(22): 2403-2407, 2022 Dec 01.
Article in English | MEDLINE | ID: covidwho-2043099

Full text: Available Collection: International databases Database: MEDLINE Main subject: Leukemia, Lymphocytic, Chronic, B-Cell / COVID-19 Topics: Long Covid / Vaccines Limits: Humans Language: English Journal: Blood Year: 2022 Document Type: Article Affiliation country: Blood.2022016815

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Leukemia, Lymphocytic, Chronic, B-Cell / COVID-19 Topics: Long Covid / Vaccines Limits: Humans Language: English Journal: Blood Year: 2022 Document Type: Article Affiliation country: Blood.2022016815